Polypharmacy Management in Elderly Patients with Multimorbidity

doi:10.12114/j.issn.1007-9572.2022.00.009

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (13): 1545-1550.DOI: 10.12114/j.issn.1007-9572.2022.00.009

• Rational Drug Use in the Elderly • Previous Articles Next Articles

Polypharmacy Management in Elderly Patients with Multimorbidity

1. School of Nursing and Health, Zhengzhou University, Zhengzhou 450001, China
2. Department of Endocrinology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China
3. Teaching and Research Department, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China

Received:2021-09-06 Revised:2021-11-22 Published:2022-05-05 Online:2022-04-22
Contact: Chunhui ZHANG
About author:
PAN W Y, ZHANG C H, ZHANG Z X, et al. Polypharmacy management in elderly patients with multimorbidity[J]. Chinese General Practice, 2022, 25 (13) : 1545-1550.

老年慢性病共病患者多重用药管理分析与评论

1．450001　河南省郑州市，郑州大学护理与健康学院
2．450014　河南省郑州市，郑州大学第二附属医院内分泌科
3．450014　河南省郑州市，郑州大学第二附属医院教研室

通讯作者: 张春慧
作者简介:
潘婉玉，张春慧，张振香，等.老年慢性病共病患者多重用药管理分析与评论[J].中国全科医学，2022，25（13）：1545-1550.[www.chinagp.net] 作者贡献：潘婉玉、林蓓蕾负责文章的构思与设计；张振香、梅永霞负责文章的可行性分析；陈静、王少阳负责文献/资料收集；潘婉玉、张春慧负责文献/资料整理；潘婉玉负责论文撰写；张春慧、翟清华负责论文的修订；潘婉玉、张振香负责文章的质量控制及审校；张春慧对文章整体负责，监督管理。
基金资助:
2020年河南省哲学社会科学规划年度项目(2020BSH015); 河南省社发领域科技攻关项目(182102310198)

1. .pdf(476KB)

Abstract

Abstract:

Active implementation of patient-centered polypharmacy management for older adults with multimorbidity can help to identify and correct the medication errors that patients may have, avoid the occurrence of potential medication errors, reduce and control the development of drug-related diseases, improve the clinical treatment effect, and delay the disease progression, thereby facilitating the achievement of targets for disease control, and improvement of quality of life of patients. In the light of problems of polypharmacy in Chinese elderly patients with multimorbidity, we summarized relevant interventions including strengthening top-level design of management, building multidisciplinary teams, innovating medication management technologies, and meeting patients'needs of drug information, providing a reference for medication management of these patients. We found that problems of polypharmacy in Chinese elderly patients are serious, and actively exploring multiple approaches to polypharmacy management based on medication features of these patients may be a key breakthrough for addressing the problems.

Key words: Elderly, Multimorbidity, Medication management, Analysis and comment

摘要：

积极落实以老年慢性病共病患者为中心的多重用药管理策略，能够识别和纠正老年慢性病共病患者的用药差错，避免潜在用药错误的发生，减少并控制药源性疾病的发生与发展，进而有助于提高疾病临床治疗效果，延缓疾病发展进程，从而有利于疾病控制达标，提高老年慢性病共病患者的生活质量。本研究针对老年慢性病共病患者存在的多重用药问题，从强化顶层设计、组建老年多学科团队、革新患者药物管理产品技术、满足患者对药物信息的需求等方面对干预措施进行总结，旨在为今后我国老年慢性病共病患者的用药管理提供参考。本研究发现，老年慢性病共病患者多重用药问题突出。基于老年人的用药特点，积极探索多途径的多重用药管理策略是目前改善老年慢性病共病患者多重用药问题的重要突破点。

关键词: 老年人, 慢性病共病, 用药管理, 分析与评论

Wanyu PAN,Chunhui ZHANG,Zhenxiang ZHANG, et al. Polypharmacy Management in Elderly Patients with Multimorbidity[J]. Chinese General Practice, 2022, 25(13): 1545-1550. DOI: 10.12114/j.issn.1007-9572.2022.00.009.
潘婉玉,张春慧,张振香等. 老年慢性病共病患者多重用药管理分析与评论[J]. 中国全科医学, 2022, 25(13): 1545-1550. DOI: 10.12114/j.issn.1007-9572.2022.00.009.

References 18

[1]	WHO. Global health risks：mortality and burden of disease attributable to selected major risks[EB/OL].(2019-09-10)[2020-12-20].
[2]	TINETTI M E, STUDENSKI S A. Comparative effectiveness research and patients with multiple chronic conditions[J]. N Engl J Med，2011，364(26):2478-2481. DOI：10.1056/NEJMp1100535.
[3]	BAHLER C, HUBER C A, BRUNGGER B，et al. Multimorbidity，health care utilization and costs in an elderly community dwelling population：a claims data based observational study[J]. BMC Health Serv Res，2015，15(1):23. DOI：10.1186/s12913-015-0698-2.
[4]	崔娟，毛凡，王志会.中国老年居民多种慢性病共存状况分析[J].中国公共卫生，2016，32(1):66-69. DOI：10.1847/zggws2016-32-01-20.
[5]	HUON J F, LENAIN E, LEGUEN J，et al. How drug use by French elderly patients has changed during the last decade[J].Drugs Real World Outcomes，2015，2(4):327-333. DOI：10.1007/s40801-015-0041-6.
[6]	World Health Organization. Medication safety in polypharmacy[EB/OL].(2019-09-20)[2020-12-20].
[7]	CHARLESWORTH C J, SMIT E, LEE D S H，et al. Polypharmacy among adults aged 65 years and older in the United States：1988—2010[J]. J Gerontol A Biol Sci Med Sc，2015，70(8):989-995. DOI：10.1093/gerona/glv013.
[8]	金福碧，郑和昕，林玲萍，等. 老年住院患者多重用药调查分析与对策[J].浙江中医药大学学报，2012，36(12):1360-1363. DOI：10.16466/j.issn1005-5509.2012.12.026.
[9]	冯娇，吕广梅. 南京市江浦街道老年人用药情况调研[J].中国卫生产业，2016，13(12):167-169. DOI：10.16659/j.cnki.1672-5654.2016.12.167.
[10]	赖小星，朱宏伟，霍晓鹏，等. 老年多重用药患者用药依从性现状及其影响因素的研究[J]. 中国护理管理，2016，16(12):1638-1642. DOI：10.3969/j.issn.1672-1756.2016.12.012.
[11]	HELD F P, BLYTH F, GNJIDIC D，et al. Association rules analysis of comorbidity and multimorbidity：the concord health and aging in men project[J]．J Gerontol A Biol Sci Med Sci，2016，71(5):625-631. DOI：10.1093/gerona/glv181.
[12]	SPINEWINE A, SCHMADER K E, BARBER N，et al. Appropriate prescribing in elderly people：how well can it be measured and optimized[J]. Lancet，2007，370(9593):173-184. DOI：10.1016/S0140-6736(07)61091-5.
[13]	张海霞，陈晓，刘金春，等. 某院老年住院患者潜在不适当用药情况[J]. 医药导报，2018，37(8):1004-1008. DOI：10.3870/j.issn.1004-0781.2018.08.018.
[14]	HYTTINEN V, JYRKKÄ J, SAASTAMOINEN L K，et al. The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons：a longitudinal 12-year study[J]. Eur J Health Econ，2019，20(2):233-243. DOI：10.1007/s10198-018-0992-0.
[15]	GARCIA R M. Five ways you can reduce inappropriate prescribing in the elderly：a systematic review[J]. J Fam Pract，2006，55(4):305-312.
[16]	SIMOES P A, SANTIAGO L M, MAURCIO K，et al. Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal：a nationwide cross-sectional study[J]. Patient Prefer Adher，2019，19(13):1569-1576. DOI：10.2147/PPA.S219346.eCollection2019.
[17]	孙艳萍，王烨，邢玉晶，等. 门诊老年患者潜在不适当用药情况调查及影响因素分析[J]. 中国新药杂志，2018，27(16):1939-1944.
[18]	曲国红，智俊娜，陈龙保，等.老年患者多重用药风险及其影响因素分析[J]. 药学与临床研究，2020，28(5):363-366. DOI：10.13664/j.cnki.pcr.2020.05.010.

Polypharmacy Management in Elderly Patients with Multimorbidity

老年慢性病共病患者多重用药管理分析与评论

RichHTML

PDF

Supplement

Knowledge

Abstract

Cite this article

share this article

References 18

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937.
[2]	WANG Xuan, SHEN Ying, XI Qian, ZHAO Can, MO Yunjian, ZHANG Wenting. Research on Treatment Burden and Influencing Factors of Patients with Multimorbidity in Rural Township Health Centers in Guangxi Zhuang Autonomous Region [J]. Chinese General Practice, 2026, 29(20): 2808-2815.
[3]	BAO Ruolin, LU Chao, FENG Xin, YE Chunmei, LAI Fenhua, NI Zuowei, YANG Dongbo, ZHENG Yongtao. Predictive Model for Breakthrough Influenza Cases in the Elderly Population: a Nested Case-control Study [J]. Chinese General Practice, 2026, 29(19): 2671-2677.
[4]	ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765.
[5]	ZHAO Jingru, JU Yvfei, XU Xiaotong, LI Dan, MENG Jie, LI Hui. A Systematic Review of the Current Situation and Influencing Factors of Medication Management for Patients with Severe Mental Disorders in China [J]. Chinese General Practice, 2026, 29(13): 1745-1752.
[6]	XIAO Yao, LIN Xiuwen, WU Qianfang, LING Xin, LIANG Yiling, LIU Jialing, SHI Lei. Health Utility Values in Chinese Patients with Multiple Chronic Diseases Based on EQ-5D: a Meta Analysis [J]. Chinese General Practice, 2026, 29(11): 1463-1472.
[7]	YANG Juan, LIU Shan, LI Fei, MENG Haodong, QIAO Hui, XIE Yongxin. Dynamic Monitoring and Analysis of Influencing Factors of Health Shocks in Rural Middle Aged and Elderly People in Ningxia: Empirical Research Based on 14 Years and Four Periods of Follow-up Data before and after Poverty Alleviation [J]. Chinese General Practice, 2026, 29(07): 914-921.
[8]	HAN Zheng, FU Fanglin, SUN Meng, PAN Yaojia, WANG Weiqiang. A Cross-sectional Study on the Relationship between the Chinese Visceral Adiposity Index and Cardiometabolic Multimorbidity in Individuals Aged 60 and Above [J]. Chinese General Practice, 2026, 29(06): 693-698.
[9]	XI Qian, SHEN Ying, ZHAO Can, JI Shuyu, PENG Houxuan, QIN Jinqiong, WANG Xuan, ZHENG Yanping, ZUO Yanli. Multimorbidity Patterns, Inpatient Care Utility, and Associated Factors in Inpatients with Multimorbidity in Township Health Centers [J]. Chinese General Practice, 2026, 29(04): 498-508.
[10]	HU Zhetao, PAN Xiaoyi. A Quantitative Research on Effectiveness of China's Community-dwelling Integrated Medical and Elderly Care Policy from the Perspective of Health Service Continuity [J]. Chinese General Practice, 2026, 29(01): 42-49.
[11]	ZHOU Yiran, SU Yinxia, YIN Feng, WU Yun, GULIJIAYINA Aiken, LU Yaoqin. The Prevalence of Multimorbidity and Complex Multimorbidity in Patients with Chronic Diseases and Patterns in Urumqi City, 2016-2022 [J]. Chinese General Practice, 2025, 28(34): 4337-4343.
[12]	YU Xinyan, YANG Jianyun, JIANG Qingru, CHEN Tao, SU Peng, WANG Siyang, LUO Zhanwu, ZHANG Haicheng. Study on the Correlation between the Course of Hypertension and Autonomic Nervous System Damage in Elderly Patients in Primary Care Institutions in Ningxia Hui Autonomous Region Based on Single Lead Wearable Electrocardiogram Device [J]. Chinese General Practice, 2025, 28(34): 4359-4370.
[13]	Expert Panel of the National Key R&D Program "Research on the Effects and Mechanisms of Multiple Types of Physical Stimulation on Body Function", Brain Function Detection and Regulation Rehabilitation Professional Committee of Chinese Association of Rehabilitation Medicine, Cerebral Small Vessel Disease Professional Committee of Beijing Neurology Association. Expert Consensus on the Effects and Efficacy Evaluation of Non-invasive Neuromodulation in Elders with Disability and Dementia [J]. Chinese General Practice, 2025, 28(34): 4258-4281.
[14]	YAN Ming, DONG Jiahui, LU Yiting, ZHAO Yang, FANG Lizheng, XU Zhijie. Treatment Burden of Disabled Persons with Multimorbidity in the Community and Its Influencing Factors [J]. Chinese General Practice, 2025, 28(32): 4015-4023.
[15]	SHI Xiaojie, YANG Xiaohua, MA Chunfang, TANG Rong. Influence of Multiple Chronic Conditions on Health Impairment in Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(32): 4009-4014.